• FirefoxInstall the new Firefox »
  •  Dow Up1.49% Nasdaq Up1.15%

    Foundation Medicine, Inc. (FMI)

    -NasdaqGS
    48.70 Up 0.73(1.52%) Mar 30, 4:00PM EDT
    Add to Portfolio
    CompetitorsGet Competitors for:
    Direct Competitor Comparison 
    FMIPVT1GHDXMYGNIndustry
    Market Cap:1.42BN/A993.79M2.51B263.31M
    Employees:293N/A7521,649156.00
    Qtrly Rev Growth (yoy):0.93N/A0.00-0.100.21
    Revenue (ttm): 61.08MN/A275.71M724.92M53.14M
    Gross Margin (ttm):0.55N/A0.800.820.47
    EBITDA (ttm):-45.55MN/A-16.76M204.42M1.10M
    Operating Margin (ttm): -0.87N/A-0.090.25-0.09
    Net Income (ttm):-52.22MN/A-24.59M110.41MN/A
    EPS (ttm):-1.87N/A-0.781.45N/A
    P/E (ttm):N/AN/AN/A24.4428.40
    PEG (5 yr expected):N/AN/A2.451.671.53
    P/S (ttm):22.88N/A3.533.513.91
     
    Pvt1 = Clarient, Inc. (privately held)
    GHDX = Genomic Health Inc.
    MYGN = Myriad Genetics Inc.
    Industry = Medical Laboratories & Research

     
    News on Direct Competitors 

    Currency in USD.